1. Home
  2. VGM vs REPL Comparison

VGM vs REPL Comparison

Compare VGM & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VGM
  • REPL
  • Stock Information
  • Founded
  • VGM 1992
  • REPL 2015
  • Country
  • VGM United States
  • REPL United States
  • Employees
  • VGM N/A
  • REPL N/A
  • Industry
  • VGM Trusts Except Educational Religious and Charitable
  • REPL Biotechnology: Pharmaceutical Preparations
  • Sector
  • VGM Finance
  • REPL Health Care
  • Exchange
  • VGM Nasdaq
  • REPL Nasdaq
  • Market Cap
  • VGM 543.9M
  • REPL 547.0M
  • IPO Year
  • VGM N/A
  • REPL 2018
  • Fundamental
  • Price
  • VGM $10.08
  • REPL $8.50
  • Analyst Decision
  • VGM
  • REPL Buy
  • Analyst Count
  • VGM 0
  • REPL 9
  • Target Price
  • VGM N/A
  • REPL $10.71
  • AVG Volume (30 Days)
  • VGM 186.2K
  • REPL 8.5M
  • Earning Date
  • VGM 01-01-0001
  • REPL 11-11-2025
  • Dividend Yield
  • VGM 4.34%
  • REPL N/A
  • EPS Growth
  • VGM N/A
  • REPL N/A
  • EPS
  • VGM 0.01
  • REPL N/A
  • Revenue
  • VGM N/A
  • REPL N/A
  • Revenue This Year
  • VGM N/A
  • REPL N/A
  • Revenue Next Year
  • VGM N/A
  • REPL N/A
  • P/E Ratio
  • VGM $988.00
  • REPL N/A
  • Revenue Growth
  • VGM N/A
  • REPL N/A
  • 52 Week Low
  • VGM $8.15
  • REPL $2.68
  • 52 Week High
  • VGM $10.07
  • REPL $17.00
  • Technical
  • Relative Strength Index (RSI)
  • VGM 53.20
  • REPL 72.53
  • Support Level
  • VGM $10.00
  • REPL $7.69
  • Resistance Level
  • VGM $10.18
  • REPL $10.29
  • Average True Range (ATR)
  • VGM 0.08
  • REPL 0.50
  • MACD
  • VGM -0.02
  • REPL 0.52
  • Stochastic Oscillator
  • VGM 30.77
  • REPL 69.81

About VGM Invesco Trust for Investment Grade Municipals (DE)

Invesco Trust for Investment Grade Municipals is active in the financial services sector. Its investment objective is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: